Jallal Bahija 4
4 · ArriVent Biopharma, Inc. · Filed Jan 29, 2024
Insider Transaction Report
Form 4
Jallal Bahija
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-25+17,884→ 17,884 totalExercise: $18.00Exp: 2034-01-24→ Common Stock (17,884 underlying)
Footnotes (1)
- [F1]These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.